Our findings, taken together with previous reports, may suggest that high IP-10 ratios in BCLC stage A patients may be associated with the development of sarcopenia via dysregulation of T-cell transfer to muscle, T-cell differentiation and receptor abnormalities [40]. Here, CXCL10 is linked to sarcopenia.